Clinical Trial Update: Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing bromfenac and besifloxacin with either prednisolone or loteprednol to prevent retinal thickening and cystoid macular edema af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Cystoid Macular Edema
• Pseudophakia

Drugs mentioned

• BROMFENAC (Bromfenac)
• Besifloxacin (besifloxacin)
• Loteprednol (loteprednol etabonate)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Innovative Medical | Conditions: Pseudophakia, Cataract Surgery | Phase 4 | Status: UNKNOWN